![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
1. (6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4h-pyrido(3,2-b)-1,4-oxazin-4-yl)methyl Disodium Phosphate Hexahydrate
2. 2h-pyrido(3,2-b)-1,4-oxazin-3(4h)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-
3. 2h-pyrido(3,2-b)-1,4-oxazin-3(4h)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-, Sodium Salt (1:2)
4. Fostamatinib
5. Fostamatinib Disodium
6. Fostamatinib Disodium Hydrate
7. Fostamatinib Disodium Salt Hexahydrate
8. R-788 Free Acid
9. R-788 Sodium
10. R-788 Sodium Anhydrous
11. R-788 Sodium Hydrate
12. R-935788 Free Acid
13. R-935788 Sodium Anhydrous
14. R-935788 Sodium Hydrate
15. R788 Free Acid
16. R788 Sodium
17. R788 Sodium Anhydrous
18. R788 Sodium Hydrate
19. R935788 Free Acid
20. R935788 Sodium Anhydrous
21. R935788 Sodium Hydrate
22. Tavalisse
1. 1025687-58-4
2. Fostamatinib Disodium
3. R788 Disodium
4. R788 (fostamatinib) Disodium
5. R 788 Sodium
6. R935788 (fostamatinib Disodium, R788)
7. R 935788 Sodium
8. Tavalisse
9. Tamatinib Fosdium
10. X9417132k8
11. 2h-pyrido(3,2-b)-1,4-oxazin-3(4h)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-, Sodium Salt (1:2)
12. Disodium;[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl Phosphate
13. R788(fostamatinib Disodium)
14. Disodium (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2h-pyrido[3,2-b][1,4]oxazin-4(3h)-yl)methyl Dihydrogen Phosphate
15. R-935788
16. Fosd
17. Fostamatinib Sodium
18. Unii-x9417132k8
19. R788(disodium)
20. R788, Fostamatinib
21. R788 Disodium (fostamatinib)
22. R788 Sodium Anhydrous
23. Schembl3657651
24. R-788 Sodium Anhydrous
25. Dtxsid70145275
26. Ex-a2146
27. R935788 (fostamatinib Disodium)
28. R935788 - Fostamatinib Disodium
29. R935788 Sodium Anhydrous
30. R-935788 Sodium Anhydrous
31. Akos026750559
32. Ccg-270264
33. Fostamatinib Disodium Salt [mi]
34. Sb40413
35. R788(disodium); Fostamatinib Disodium
36. Ac-28433
37. As-16263
38. C71107
39. J-000725
40. J-518183
41. Q27293710
42. (6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4h-pyrido(3,2-b)-1,4-oxazin-4-yl)methyl Disodium Phosphate
43. 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2h-pyrido[3,2-b]-1,4-oxazi N-3(4h)-one Sodium Salt
44. Disodium,[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl Phosphate
Molecular Weight | 624.4 g/mol |
---|---|
Molecular Formula | C23H24FN6Na2O9P |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 9 |
Exact Mass | 624.11218009 g/mol |
Monoisotopic Mass | 624.11218009 g/mol |
Topological Polar Surface Area | 192 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 893 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 1 | |
---|---|
Drug Name | TAVALISSE |
Active Ingredient | FOSTAMATINIB DISODIUM |
Company | RIGEL PHARMS INC (Application Number: N209299) |
Tavlesse is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments.
B02BX